Abstract
Sleep disorders have a high prevalence both in the general population and especially in specific populations such older adults and oncologic patients. Impacting on quality of life, they often translate in drug prescription, with consequent increased risk of drug-drug interactions and adverse drug reactions. In the last years several products derived from plants have been developed with the aim of treating insomnia with lower risk of side effects. Despite several studies have been performed with this aim, the available evidence is inconclusive, and reviews summarizing the most recent evidences on the effectiveness of plant-derived products in treating insomnia are lacking.
This narrative review aims at summarizing the evidences of the mechanism of action, effectiveness and safety of the most commonly used plant-derived products for the treatment of sleep disorders (Valerian, Lemon balm, Passionflower, Chamomile, Hops, and Jujube).
Keywords
- Insomnia
- Phytotherapy
- Valerian
- Lemon balm
- Passionflower
- Chamomile
- Hops
- Jujube
This is a preview of subscription content, access via your institution.
Buying options
References
Ohayon MM (2011) Epidemiological overview of sleep disorders in the general population. Sleep Med Res 2(1):1–9
Katz DA, McHorney CA (1998) Clinical correlates of insomnia in patients with chronic illness. Arch Intern Med 158(10):1099–1107
Dujardin S, Pijpers A, Pevernagie D (2018) Prescription drugs used in insomnia. Sleep Med Clin 13(2):169–182
Romero K, Goparaju B, Russo K, Westover MB, Bianchi MT (2017) Alternative remedies for insomnia: a proposed method for personalized therapeutic trials. Nat Sci Sleep 9:97–108
Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL (2017) Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med 13(2):307–349
Riemann D, Baglioni C, Bassetti C, Bjorvatn B, Dolenc Groselj L, Ellis JG et al (2017) European guideline for the diagnosis and treatment of insomnia. J Sleep Res 26(6):675–700
Sarris J, Byrne GJ (2011) A systematic review of insomnia and complementary medicine. Sleep Med Rev 15(2):99–106
Pearson NJ, Johnson LL, Nahin RL (2006) Insomnia, trouble sleeping, and complementary and alternative medicine: analysis of the 2002 national health interview survey data. Arch Intern Med 166(16):1775–1782
Ross SM (2014) Psychophytomedicine: an overview of clinical efficacy and phytopharmacology for treatment of depression, anxiety and insomnia. Holist Nurs Pract 28(4):275–280
Anonymous (2018) Valerianae radix [Internet]. European Medicines Agency. [cited 2019 Dec 10]. Available from: https://www.ema.europa.eu/en/medicines/herbal/valerianae-radix
Benke D, Barberis A, Kopp S, Altmann K-H, Schubiger M, Vogt KE et al (2009) GABA A receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts. Neuropharmacology 56(1):174–181
Dietz BM, Mahady GB, Pauli GF, Farnsworth NR (2005) Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro. Brain Res Mol Brain Res 138(2):191–197
Anderson GD, Elmer GW, Taibi DM, Vitiello MV, Kantor E, Kalhorn TF et al (2010) Pharmacokinetics of valerenic acid after single and multiple doses of valerian in older women. Phytother Res 24(10):1442–1446
Choi H-S, Ko BS, Kim HD, Hong K-B, Suh HJ (2017) Effect of Valerian/Hop mixture on sleep-related behaviors in Drosophila melanogaster. Biol Pharm Bull 40(7):1101–1110
Choi H-S, Hong K-B, Han SH, Suh HJ (2018) Valerian/Cascade mixture promotes sleep by increasing non-rapid eye movement (NREM) in rodent model. Biomed Pharmacother 99:913–920
Sahu S, Ray K, Yogendra Kumar MS, Gupta S, Kauser H, Kumar S et al (2012) Valeriana wallichii root extract improves sleep quality and modulates brain monoamine level in rats. Phytomedicine 19(10):924–929
Xu K, Lin Y, Zhang R, Lan M, Chen C, Li S et al (2015) Evaluation of safety of iridoids rich fraction from Valeriana jatamansi Jones: acute and sub-chronic toxicity study in mice and rats. J Ethnopharmacol 172:386–394
Kim J, Lee SL, Kang I, Song YA, Ma J, Hong YS et al (2018) Natural products from single plants as sleep aids: a systematic review. J Med Food 21(5):433–444
Dey A, Dey A (2013) Phytotherapy against insomnia: extravagant claims or an alternative medicine? Pak J Biol Sci 16(3):148–150
Regestein QR (2011) Is there anything special about valerian? Menopause 18(9):937–939
Salter S, Brownie S (2010) Treating primary insomnia – the efficacy of valerian and hops. Aust Fam Physician 39(6):433–437
Fernández-San-Martín MI, Masa-Font R, Palacios-Soler L, Sancho-Gómez P, Calbó-Caldentey C, Flores-Mateo G (2010) Effectiveness of Valerian on insomnia: a meta-analysis of randomized placebo-controlled trials. Sleep Med 11(6):505–511
Taavoni S, Ekbatani N, Kashaniyan M, Haghani H (2011) Effect of valerian on sleep quality in postmenopausal women: a randomized placebo-controlled clinical trial. Menopause 18(9):951–955
Barton DL, Atherton PJ, Bauer BA, Moore DF, Mattar BI, Lavasseur BI et al (2011) The use of Valeriana officinalis (Valerian) in improving sleep in patients who are undergoing treatment for cancer: a phase III randomized, placebo-controlled, double-blind study (NCCTG Trial, N01C5). J Support Oncol 9(1):24–31
Cuellar NG, Ratcliffe SJ (2009) Does valerian improve sleepiness and symptom severity in people with restless legs syndrome? Altern Ther Health Med 15(2):22–28
Maroo N, Hazra A, Das T (2013) Efficacy and safety of a polyherbal sedative-hypnotic formulation NSF-3 in primary insomnia in comparison to zolpidem: a randomized controlled trial. Indian J Pharm 45(1):34–39
Thomas K, Canedo J, Perry PJ, Doroudgar S, Lopes I, Chuang HM et al (2016) Effects of valerian on subjective sedation, field sobriety testing and driving simulator performance. Accid Anal Prev 92:240–244
Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M (2008) Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med 4(5):487–504
Mann C, Staba EJ (1986) The chemistry, pharmacology, and commercial formulations of chamomile. Herbs, spices, and medicinal plants : recent advances in botany, horticulture, and pharmacology (USA) [Internet]. [cited 2019 Dec 10]; Available from: http://agris.fao.org/agris-search/search.do?recordID=US8700832
Mulinacci N, Romani A, Pinelli P, Vincieri FF, Prucher D (2000) Characterization ofMatricaria recutita L. Flower extracts by HPLC-MS and HPLC-DAD analysis. Chromatographia 51(5):301–307
Barene I, Daberte I, Zvirgzdina L, Iriste V (2003) The complex technology on products of German chamomile. Medicina (Kaunas) 39(Suppl 2):127–131
Loggia RD, Traversa U, Scarcia V, Tubaro A (1982) Depressive effects of Chamomilla recutita (L.) Rausch, tubular flowers, on central nervous system in mice. Pharmacol Res Commun 14(2):153–162
Viola H, Wasowski C, Levi de Stein M, Wolfman C, Silveira R, Dajas F et al (1995) Apigenin, a component of Matricaria recutita flowers, is a central benzodiazepine receptors-ligand with anxiolytic effects. Planta Med 61(3):213–216
Salgueiro JB, Ardenghi P, Dias M, Ferreira MB, Izquierdo I, Medina JH (1997) Anxiolytic natural and synthetic flavonoid ligands of the central benzodiazepine receptor have no effect on memory tasks in rats. Pharmacol Biochem Behav 58(4):887–891
Yamada K, Miura T, Mimaki Y, Sashida Y (1996) Effect of inhalation of chamomile oil vapour on plasma ACTH level in ovariectomized-rat under restriction stress. Biol Pharm Bull 19(9):1244–1246
Adib-Hajbaghery M, Mousavi SN (2017) The effects of chamomile extract on sleep quality among elderly people: a clinical trial. Complement Ther Med 35:109–114
Abdullahzadeh M, Matourypour P, Naji SA (2017) Investigation effect of oral chamomilla on sleep quality in elderly people in Isfahan: a randomized control trial. J Educ Health Promot 6:53
Chang S-M, Chen C-H (2016) Effects of an intervention with drinking chamomile tea on sleep quality and depression in sleep disturbed postnatal women: a randomized controlled trial. J Adv Nurs 72(2):306–315
Zick SM, Wright BD, Sen A, Arnedt JT (2011) Preliminary examination of the efficacy and safety of a standardized chamomile extract for chronic primary insomnia: a randomized placebo-controlled pilot study. BMC Complement Altern Med 11:78
Hieu TH, Dibas M, Surya Dila KA, Sherif NA, Hashmi MU, Mahmoud M et al (2019) Therapeutic efficacy and safety of chamomile for state anxiety, generalized anxiety disorder, insomnia, and sleep quality: a systematic review and meta-analysis of randomized trials and quasi-randomized trials. Phytother Res 33(6):1604–1615
Cornu C, Remontet L, Noel-Baron F, Nicolas A, Feugier-Favier N, Roy P et al (2010) A dietary supplement to improve the quality of sleep: a randomized placebo controlled trial. BMC Complement Altern Med 10:29
Shou CH, Wang J, Zheng XX, Guo DW (2001) Inhibitory effect of jujuboside A on penicillin sodium induced hyperactivity in rat hippocampal CA1 area in vitro. Acta Pharmacol Sin 22(11):986–990
Zhang M, Ning G, Shou C, Lu Y, Hong D, Zheng X (2003) Inhibitory effect of jujuboside A on glutamate-mediated excitatory signal pathway in hippocampus. Planta Med 69(8):692–695
Lu Y-J, Zhou J, Zhang S-M, Zhang H-Y, Zheng X-X (2005) Inhibitory effects of jujuboside A on EEG and hippocampal glutamate in hyperactive rat. J Zhejiang Univ Sci B 6(4):265–271
Wang C, You Z, Xia Q, Xiong T, Xia Y, Yao D (2007) Upregulation of Mark3 and Rpgrip1 mRNA expression by jujuboside A in mouse hippocampus. Acta Pharmacol Sin 28(3):334–338
Chen CY-C (2009) Chemoinformatics and pharmacoinformatics approach for exploring the GABA-A agonist from Chinese herb suanzaoren. J Taiwan Inst Chem Eng 40(1):36–47
You Z, Xia Q, Liang F, Tang Y, Xu C, Huang J et al (2010) Effects on the expression of GABAA receptor subunits by jujuboside A treatment in rat hippocampal neurons. J Ethnopharmacol 128(2):419–423
Hu L-L, Zhang X, Liu W-J, Li M, Zhang Y-H (2015) Suan zao ren tang in combination with zhi zi chi tang as a treatment protocol for insomniacs with anxiety: a randomized parallel-controlled trial. Evid Based Complement Alternat Med 2015:913252
Xie C, Gu Y, Wang W-W, Lu L, Fu D, Liu A et al (2013) Efficacy and safety of Suanzaoren decoction for primary insomnia: a systematic review of randomized controlled trials. BMC Complement Altern Med 13:18
Miraj S, Rafieian-Kopaei N, Kiani S (2017) Melissa officinalis L: a review study with an antioxidant prospective. J Evid Based Complement Altern Med 22(3):385–394
Haybar H, Javid AZ, Haghighizadeh MH, Valizadeh E, Mohaghegh SM, Mohammadzadeh A (2018) The effects of Melissa officinalis supplementation on depression, anxiety, stress, and sleep disorder in patients with chronic stable angina. Clin Nutr ESPEN 26:47–52
Cases J, Ibarra A, Feuillère N, Roller M, Sukkar SG (2011) Pilot trial of Melissa officinalis L. leaf extract in the treatment of volunteers suffering from mild-to-moderate anxiety disorders and sleep disturbances. Med J Nutr Metab 4(3):211–218
Appel K, Rose T, Fiebich B, Kammler T, Hoffmann C, Weiss G (2011) Modulation of the γ-aminobutyric acid (GABA) system by Passiflora incarnata L. Phytother Res 25(6):838–843
Ngan A, Conduit R (2011) A double-blind, placebo-controlled investigation of the effects of Passiflora incarnata (passionflower) herbal tea on subjective sleep quality. Phytother Res 25(8):1153–1159
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Lelli, D., Cortese, L., Pedone, C. (2021). Use of Plant-Derived Natural Products in Sleep Disturbances. In: Barreto, G.E., Sahebkar, A. (eds) Pharmacological Properties of Plant-Derived Natural Products and Implications for Human Health. Advances in Experimental Medicine and Biology, vol 1308. Springer, Cham. https://doi.org/10.1007/978-3-030-64872-5_15
Download citation
DOI: https://doi.org/10.1007/978-3-030-64872-5_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-64871-8
Online ISBN: 978-3-030-64872-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)